Funding Rounds
Affectis Pharmaceuticals Series C (2006, $12M)
Affectis PharmaceuticalsDrugs developer for the treatment of neurodegenerative and neuroinflammatory diseases.
Summary
Stage: Series C
Raised Amount: $12.90M
Stage: Series C
Raised Amount: $12.90M
